T

Protara Therapeutics
D

TARA

2.53000
USD
0.00
(0.00%)
مفتوح الان
حجم التداول
267
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
52,193,323
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Protara Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatmentoptions. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).